Your browser doesn't support javascript.
loading
Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care.
Huttner, Hagen B; Gerner, Stefan T; Kuramatsu, Joji B; Connolly, Stuart J; Beyer-Westendorf, Jan; Demchuk, Andrew M; Middeldorp, Saskia; Zotova, Elena; Altevers, Julia; Andersohn, Frank; Christoph, Mary J; Yue, Patrick; Stross, Leonhard; Schwab, Stefan.
Afiliação
  • Huttner HB; Department of Neurology, University Hospital Erlangen, Germany (H.B.H., S.T.G., J.B.K., S.S.).
  • Gerner ST; Department of Neurology, University Hospital Giessen, Germany (H.B.H.).
  • Kuramatsu JB; Department of Neurology, University Hospital Erlangen, Germany (H.B.H., S.T.G., J.B.K., S.S.).
  • Connolly SJ; Department of Medicine, Dresden University Clinic Fetscherstr, Germany (J.B.-W.).
  • Beyer-Westendorf J; Population Health Research Institute, McMaster University, Canada (S.J.C., E.Z.).
  • Demchuk AM; Department of Neurology, University Hospital Erlangen, Germany (H.B.H., S.T.G., J.B.K., S.S.).
  • Middeldorp S; Departments of Clinical Neurosciences (A.M.D.) and Radiology (A.M.D.), University of Calgary, Canada.
  • Zotova E; Department of Internal Medicine and Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands (S.M.).
  • Altevers J; Population Health Research Institute, McMaster University, Canada (S.J.C., E.Z.).
  • Andersohn F; Xcenda GmbH, Germany (J.A., F.A.).
  • Christoph MJ; Xcenda GmbH, Germany (J.A., F.A.).
  • Yue P; Portola Pharmaceuticals, Inc (now Alexion, AstraZeneca Rare Disease), Boston, MA (M.J.C.).
  • Stross L; Former employee of Portola Pharmaceuticals, Inc (now Alexion, AstraZeneca, Rare Disease), Boston, MA (P.Y., L.S.).
  • Schwab S; Former employee of Portola Pharmaceuticals, Inc (now Alexion, AstraZeneca, Rare Disease), Boston, MA (P.Y., L.S.).
Stroke ; 53(2): 532-543, 2022 02.
Article em En | MEDLINE | ID: mdl-34645283
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Fator Xa / Hemorragia Cerebral / Inibidores do Fator Xa / Hematoma Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Stroke Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes / Fator Xa / Hemorragia Cerebral / Inibidores do Fator Xa / Hematoma Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Stroke Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos